|
Title: A patient with lung cancer receives filgrastim (Neupogen) after chemotherapy to reduce neutropenia. ... Post by: mecd1991 on Jan 24, 2018 A patient with lung cancer receives filgrastim (Neupogen) after chemotherapy to reduce neutropenia. The patient reports a moderate degree of bone pain. What will the nurse do?
a. Obtain an order to administer acetaminophen. b. Request an order for a complete blood count (CBC). c. Request an order to reduce the dose of filgrastim. d. Suspect metastasis of the cancer to the bone. Title: A patient with lung cancer receives filgrastim (Neupogen) after chemotherapy to reduce neutropenia. ... Post by: courtneysparrow on Jan 24, 2018 ANS: A
Bone pain occurs in about 25 of patients receiving filgrastim. It can be treated with a nonopioid analgesic and, if necessary, an opioid analgesic. Leukocytosis can occur, but bone pain is not a symptom of this, so a CBC is not indicated. Bone pain is not an indication for reducing the dose of filgrastim. Because moderate bone pain is a common adverse effect, metastasis to the bone is less likely. |